Comparison of Efficacy and Safety between Conbercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: A Meta-Analysis of Randomized Controlled Trials
Conclusion: Conbercept was similar to ranibizumab in terms of efficacy and safety for the treatment of nAMD in China. Further studies with longer term observation are needed to support this conclusion.
Source: Ophthalmic Research - Category: Opthalmology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | China Health | Databases & Libraries | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Science | Study